Hard to understand. Only thing is Generex's history both recent and distant past is full of plans that have not been carried out. Add Veneto and the use of shares in these terrible financing deals and you have a lot of disbelieving going on.

We need a big win to change the perception. Whether it be stellar clinical data or one of these partner deals closing that brings a good chunk of money into the company.

Even at that it is hard to think the statement you posted couldn't get the share price well out of the 40's and even 50's IMO.

Looking forward to hearing Joe and team lay it all out tomorrow.